小型动物喷射注射技术增强汉坦病毒DNA疫苗免疫原性
研究在叙利亚仓鼠中评估人用皮内喷射注射装置用于递送汉坦病毒DNA疫苗。结果显示喷射注射递送的疫苗免疫原性显著高于针筒注射或基因枪,且优化后的安第斯病毒DNA疫苗可保护仓鼠免于致死性疾病。
要点
- 人用皮内喷射注射装置可适配仓鼠皮下或肌内递送DNA疫苗。
- 喷射注射递送的汉坦病毒DNA疫苗免疫原性高于针筒或基因枪。
- 优化安第斯病毒DNA疫苗首次在仓鼠模型中显示保护效力。
核心结论
- 改造人用皮内喷射注射装置用于小型动物皮下和肌内递送DNA疫苗可增强免疫原性。
研究设计与样本
- 在叙利亚仓鼠中评估商业化人用皮内喷射注射装置(0.1 mL体积)递送汉坦病毒DNA疫苗。
- 直接比较六种优化与非优化汉坦病毒DNA疫苗在仓鼠中的免疫原性。
主要发现
- 喷射注射递送的汉坦病毒DNA疫苗免疫原性显著高于针筒注射或基因枪递送。
- 调整装置使用方式可将疫苗递送至皮下组织或穿过皮肤进入肌肉。
- 在表皮、表皮下和成纤维细胞中检测到RNA和/或抗原表达。
- 优化(包括密码子使用和mRNA稳定性)并非对所有受试疫苗都提高免疫原性。
- 优化安第斯病毒DNA疫苗保护仓鼠免于致死性疾病,为首次显示该疫苗在仓鼠模型的主动保护效力。
临床怎么用
- 小型动物DNA疫苗评价中可考虑采用喷射注射替代针筒或基因枪以增强免疫原性。
- 人用皮内喷射装置经调整可用于仓鼠皮下或肌内递送,支持核酸类医学应对措施开发。
局限性
- 研究仅在小动物(叙利亚仓鼠)中进行,结果外推至其他物种需谨慎。
- 目前尚无专用于小型动物的一次性注射器喷射注射装置。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
DNA vaccine evaluation in small animals is hampered by low immunogenicity when the vaccines are delivered using a needle and syringe. To overcome this technical hurdle we tested the possibility that a device developed for human intradermal medicine delivery might be adapted to successfully deliver a DNA vaccine to small animals. Disposable syringe jet injection (DSJI) does not currently exist for small animals. However, a commercialized, human intradermal device used to to administer medicines to the human dermis in a 0.1 mL volume was evaluated in Syrian hamsters. Here, we found that hantavirus DNA vaccines administered to hamsters using DSJI were substantially more immunogenic than the same vaccines delivered by needle/syringe or particle mediated epidermal delivery (gene gun) vaccination. By adjusting how the device was used we could deliver vaccine to either subcutaneous tissues, or through the skin into the muscle. RNA and/or antigen expression was detected in epidermal, subepidermal and fibroblast cells. We directly compared six optimized and non-optimized hantavirus DNA vaccines in hamsters. Optimization, including codon-usage and mRNA stability, did not necessarily result in increased immunogenicity for all vaccines tested; however, optimization of the Andes virus (ANDV) DNA vaccine protected vaccinated hamsters from lethal disease. This is the first time active vaccination with an ANDV DNA vaccine has shown protective efficacy in the hamster model. The adaptation of a human intradermal jet injection device for use as a method of subcutaneous and intramuscular jet injection of DNA vaccines will advance the development of nucleic acid based medical countermeasures for diseases modeled in hamsters.
引用
- Brocato RL, Kwilas SA, Josleyn MD, et al. Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines. Vaccine. 2021. PMID: 33483212. doi:10.1016/j.vaccine.2021.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。